HSDD

Young People Can Suffer from Sexual DysfunctionAlthough most young people have a healthy sex life, many—and particularly young women— may have one or more sexual dysfunction issues, according to results of health survey.
Impact of Delivery Type on Female Sexual Function ExploredThe route of delivery of a child does not have a long-term effect on female sexual dysfunction in primipara mothers, according to a study.
Brain activation differs in women with HSDD and those with normal sexual functionStudies of hypoactive sexual desire disorder (HSDD) traditionally have focused on behavioral and biologic components of the disease. A new multicenter study, however, sheds light on brain activation patterns during sexual arousal in women with the condition.
Breast cancer survivors report poor sexual healthAn Austrian study highlights the need for ob/gyns to counsel breast cancer survivors about sexual health issues, even years after their treatment for the disease
Letters: Hypoactive desire disorder a 'true' conditionIn this month's Letters to the Editor, one reader responds to an article on testosterone therapy in women and another looks to address urology's work force shortage.
Uro Pipeline: Bladder Ca drug-device combination begins second phase Ib trialA bladder cancer drug-device combination, a localized prostate cancer agent, and a new surgical robot are among other treatments in the pipeline discussed in this round-up.
Top 5 things to know about “female Viagra”FDA’s long-awaited approval of Addyi (flibanserin) to treat hypoactive sexual desire disorder in premenopausal women, is significant for the prescribing community.
Urology Product Preview April 2014Drugs and devices in the pipeline from Astellas Pharma, Medivation, Repros Therapeutics, Metamark Genetics, Argos Therapeutics, S1 Biopharma, Ipsen, Sprout Pharmaceuticals, Antigen Express, Generex Biotechnology, Veloxis Pharmaceuticals, and Absorption Pharmaceuticals.